A24.1 Acute and fulminating melioidosis

Name of the Condition

• Acute and fulminating melioidosis

Summary

Acute and fulminating melioidosis is a severe, rapidly progressing form of melioidosis caused by Burkholderia pseudomallei. It is characterized by sudden onset of systemic illness, often with high fever, respiratory distress, and potential for multi-organ failure. The condition requires prompt medical attention due to its aggressive nature and high mortality risk if untreated.

Causes

Acute and fulminating melioidosis is caused by Burkholderia pseudomallei, a gram-negative bacterium found in soil and water. Infection occurs through inhalation, ingestion, or skin inoculation of contaminated material. The bacteria can spread quickly through the bloodstream, leading to severe systemic involvement.

Risk Factors

• Residing in or traveling to tropical regions where Burkholderia pseudomallei is endemic (e.g., Southeast Asia, northern Australia).
• Underlying conditions such as diabetes, chronic lung disease, or immunosuppression, which increase susceptibility to severe disease.
• High levels of environmental exposure (e.g., during floods or monsoons) that increase contact with contaminated soil or water.

Symptoms

• High fever and chills
• Severe respiratory symptoms (e.g., cough, shortness of breath)
• Rapid onset of sepsis or septic shock
• Multi-organ failure (e.g., liver, kidney, or lung involvement)
• Skin lesions or abscesses in some cases
• Neurological symptoms (e.g., confusion, seizures) in severe instances

Diagnosis

Diagnosis is based on clinical presentation, exposure history, and laboratory testing. Confirmation typically involves culturing Burkholderia pseudomallei from blood, sputum, or other bodily fluids. Rapid molecular tests may be used in endemic areas for early detection.

Treatment Options

• Antibiotics: Intravenous antibiotics (e.g., ceftazidime or meropenem) are initiated immediately for severe cases.
• Supportive Care: Management of sepsis, organ failure, and respiratory support as needed.
• Long-Term Therapy: Extended oral antibiotics (e.g., trimethoprim-sulfamethoxazole) may be required to prevent relapse.

Prognosis and Follow-Up

Prognosis is guarded due to the fulminating nature of the disease, with high mortality if treatment is delayed. Survivors require close monitoring for relapse or chronic infection. Follow-up includes regular clinical assessments and imaging to evaluate organ function.

Complications

• Septic shock and multi-organ failure
• Respiratory failure requiring mechanical ventilation
• Chronic pulmonary or systemic infection
• Neurological damage from severe sepsis

Lifestyle & Prevention

• Avoid contact with contaminated soil or water in endemic areas.
• Use protective gear (e.g., gloves, masks) during high-risk activities (e.g., farming, flood cleanup).
• Seek prompt medical care for any signs of infection after potential exposure.

When to Seek Professional Help

Seek immediate medical attention if experiencing sudden high fever, severe respiratory distress, or signs of sepsis (e.g., confusion, low blood pressure) after potential exposure to Burkholderia pseudomallei.

Tips for Medical Coders

Document the acute and fulminating nature of the condition, including clinical severity and organ involvement, to support accurate coding. Ensure laboratory confirmation of Burkholderia pseudomallei is noted if available, as it strengthens diagnostic specificity.